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a  b  s  t  r  a  c  t
Fibromyalgia syndrome (FMS) is a chronic painful syndrome and the coexistence of a painful
condition caused by Temporomandibular Disorders (TMD) and FMS has been frequently
raised for several studies; however, a more likely hypothesis is that a set of FMS char-
acteristics may lead to the onset of TMD symptoms and they are not merely coexisting
conditions. Therefore, our aim is presenting a review of literature about the relation between
ﬁbromyalgia and the signs and symptoms of temporomandibular disorders. For this pur-
pose, a bibliographic search was performed for the period of 1990–2013, in the Medline,
Pubmed, Lilacs and Scielo databases, using the keywords ﬁbromyalgia, temporomandibular
disorders and facial pain. Here we present a set of ﬁndings in the literature showing that
ﬁbromyalgia can lead to TMD symptoms. These studies demonstrated greater involvement
of  the stomatognathic system in FMS and myogenic disorders of masticatory system are
most commonly found in those patients. FMS appears to have a series of characteristics
that  constitute predisposing and triggering factors for TMD.
©  2014 Elsevier Editora Ltda. All rights reserved.
Disfunc¸ão  temporomandibular  na  síndrome  da  ﬁbromialgia:
comunicac¸ão  breve
alavras-chave:
r  e  s  u  m  o
A síndrome da ﬁbromialgia (SFM) é uma síndrome dolorosa crônica. A coexistência de
ibromialgia uma condic¸ão dolorosa causada pela disfunc¸ão temporomandibular (DTM) e pela SFM tem
 descrita por vários estudos. No entanto, a hipótese mais provávelor facial sido  frequentemente
índrome da disfunc¸ão da
rticulac¸ão temporomandibular
é  que um conjunto de características da SFM pode levar ao aparecimento de sintomas
de  DTM e elas não são apenas condic¸ões coexistentes. Por isso, o objetivo deste estudo
é  apresentar uma revisão da literatura sobre a relac¸ão entre a ﬁbromialgia e os sinais e
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sintomas da disfunc¸ão temporomandibular. Para este ﬁm, fez-se uma pesquisa bibliográ-
ﬁca  que envolveu o período de 1990 a 2013 nas bases de dados Medline, Pubmed, Lilacs e
Scielo. Foram usadas as palavras-chave ﬁbromialgia, disfunc¸ão temporomandibular e dor
facial. Neste trabalho, apresenta-se um conjunto de achados da literatura que mostram
que  a ﬁbromialgia pode levar a sintomas de DTM. Estes estudos mostraram um maior
envolvimento do sistema estomatognático na SFM e que os distúrbios miogênicos do sis-
tema  mastigatório são os mais comumente encontrados nesses pacientes. A SFM parece ter
uma  série de características que constituem fatores predisponentes e desencadeantes para
a  DTM.
© 2014 Elsevier Editora Ltda. Todos os direitos reservados.Introduction
Fibromyalgia syndrome (FMS) is a chronic painful syndrome of
unknown etiology that affects predominantly women.1 New
criteria for clinical diagnosis of ﬁbromyalgia have been pro-
posed by the American College of Rheumatology (ACR) due
to recognition of the importance of cognitive problems and
somatic symptoms.2
They identiﬁed two variables that best deﬁned ﬁbromyalgia
and its symptom spectrum: the widespread pain index (WPI)
and the symptom severity (SS) scale. The SS scale score is
the sum of the severity of the 3 symptoms (fatigue, waking
unrefreshed, cognitive symptoms) plus the extent (severity)
of somatic symptoms in general. According to this study,2 a
patient satisﬁes diagnostic criteria for ﬁbromyalgia if the fol-
lowing 3 conditions are met: WPI  ≥ 7 and SS scale score ≥ 5 or
WPI  3–6 and SS scale score ≥ 9; furthermore, symptoms have
been present at a similar level for at least 3 months and the
patient does not have a disorder that would otherwise explain
the pain.
Other symptoms such as sleep disturbances, depres-
sion and fatigue are also associated with this disease. In
addition, the coexistence of a painful condition caused by
temporomandibular disorders (TMD) and ﬁbromyalgia has
been frequently raised for several studies. TMD are a set of
conditions affecting the masticatory muscles or joints and
exhibiting pain as their primary characteristic.3
Hedenberg-Magnusson et al.4 found that FMS  patients have
frequent and severe symptoms of TMD  and 94% reported local
pain from the temporomandibular system with a mean dura-
tion of 12 years. General body pain had a signiﬁcantly longer
duration than TMD,  which indicates that ﬁbromyalgia starts
in other parts of the body and later extends to the temporo-
mandibular region. Therefore, a more  likely hypothesis is that
a set of FMS  symptoms may lead to the onset of TMD symp-
toms, while there is a TMD  subgroup of patients that could
present widespread pain, but do not meet the criteria for
ﬁbromyalgia.
After all, our objective is presenting a review of literature
about the relation between ﬁbromyalgia and the signs and
symptoms of temporomandibular disorders.
MethodsBibliographic search of electronic bibliographic databases
(Medline, Pubmed, Lilacs and Scielo) for the period fromJanuary1990 to December2013 was performed utilizing the
keywords:
“Temporomandibular Disorders” or “Facial Pain” combined
with “Fibromyalgia”.
Initially, 122 pages of results were found. Then, two  inde-
pendent reviewers read the abstracts and those that were
selected by consensus to the following inclusion criteria:
Patients with ﬁbromyalgia and TMD diagnosis. We  excluded
articles, which did not address only these two pathologies
and those that did not aim to relate the symptoms of both
syndromes.
We selected 158 articles with cross-sectional design,
which were then read and evaluated for inclusion into the
literature review. Considering the heterogeneity of the stud-
ies, additional inclusion criteria for research articles were:
Investigations of the relationship and differences between
ﬁbromyalgia and TMD (n = 13 papers selected), prevalence
(n = 7 papers selected), and investigations about facial pain
symptoms in FMS (n = 8 papers selected).
Results
TMD  prevalence  in  FMS
FMS  patients are 31 times more  likely to have a diagnosis of
facial muscle pain than patients without the condition.5 More-
over, the literature points to a high prevalence of TMD  in these
patients (Table 1).
Only two studies used clinical examination for TMD  diag-
noses and ﬁve studies used the Research Diagnostic Criteria
for Temporomandibular Disorder (RDC/TMD) that is a gold
standard tool for TMD detection. Regardless of the evaluat-
ing methods, these studies show a prevalence range between
59.37% and 93.7%, which can be explained by many  factors.
One of them are the different populations studied (e.g. Italy,6
United States,7–9 Turkey10 and Brazil5,11).
Moreover, whether ﬁbromyalgia starts in other parts of the
body and later extends to the temporomandibular region,4 the
time of diagnosis of ﬁbromyalgia could inﬂuence on preva-
lence results. Therefore, chronic FMS patient might present a
greater number of symptoms of TMD.
TMD  signs  and  symptoms  in  FMSAccording to the American Dental Association (ADA), TMD
were deﬁned as cases where you have pain in the pre-auricular
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Table 1 – Prevalence of TMD  in ﬁbromyalgia syndrome.
Authors n Age range Evaluation method for TMD Prevalence
Plesh et al. (1996)7 60 >18 years RDC/TMD 75%
Rhodus et at. (2003)8 67 47.6 ± 2.3 Clinical Examination 67.6%
Salvetti et al. (2007)6 93 50.1 ± 9.8 RDC/TMD 79.56%
Balasubramanian et al. (2007)9 32 >18 years RDC/TMD 59.37%




Fujarra et al. (2008)11 48 46.3 ± 8.7 RDC/TMD 93.7%








































nRDC/TMD, Research Diagnostic Criteria for Temporomandibular Diso
egion, the temporomandibular joint or masticatory muscles,
imitation or deviation of mandibular movement, temporo-
andibular joint noise during the functioning of mandibular
nd palpation and abnormal relation of static and dynamic
clusal.12
Just recently, psychological and behavioral factors have
ecome well-established inﬂuences upon a wide range of
ain conditions including TMD  pain. Genetics and sensory
rocessing also contribute to TMD  etiology.3
Individuals with these conditions (e.g. FMS  and TMD)
isplay diffuse hyperalgesia (increased pain to normally
ainful stimuli) and/or allodynia (pain to normally nonpainful
timuli). This abnormality across conditions suggests that
hese individuals have a fundamental problem with pain
r sensory processing rather than an abnormality conﬁned
o a speciﬁc region of the body where pain is perceived to
riginate.13
Plesh et al.7 reported that a small proportion of patients
ith TMD  (18.4%) also had FMS,  but most of those with
MS  (75.0%) satisﬁed criteria for muscular (myofascial) TMD.
atients with FMS  had lower pain thresholds and more  severe
anifestations of all disease measures (e.g., pain, fatigue and
leep) compared to those with TMD.  They also had more
ainful body regions. Patients with FMS  also differed signif-
cantly from those with TMD  in self-reported work ability and
ealth assessment. The features that best differentiated FMS
rom TMD  are functional disability, reports of work difﬁculty,
nd general dissatisfaction with health.
In addition, FMS  patients present high prevalence of
yofascial pain on palpation and during mandibular move-
ents, as a high self-reported daytime clenching and
rinding.5
MD  onset  in  FMS
n ﬁbromyalgia, TMD  has an insidious onset, and etiology is
ot fully known, in which biochemical abnormalities, neu-
oendocrine, and mechanisms of central sensitization may
lay an important etiological role.14 According to Saltareli
t al.15 the complexity of factors involved in the frame of
bromyalgia, to the question of diagnosis and the proper
pproach by health professionals, shows the need for more
tudies that propose to expand the understanding of the
ssues experienced by these patients.
High frequency of headache (78%), facial pain and tired-
ess of the jaws were found in FMS  and about ﬁfty percentof the patients of Hedenberg-Magnusson et al.4 study also
complained about difﬁculties to open the mouth and to chew.
This study shows that patients with ﬁbromyalgia often suffer
from symptoms of TMD, and that the intensity of the pain is
correlated to general body pain. These ﬁndings indicate that
ﬁbromyalgia is one of the causes of TMD.
As well as FMS,  in temporomandibular disorders,
widespread pain is presented. Some studies have showed
that patients with TMD frequently describe pain in multiple
body parts16 and overlap of tender and trigger points was
found in both patient groups17 which is inconsistent with the
pathogenetic concept of myofascial trigger points and local
disturbances of orofacial structures as the only ones causing
TMD  chronic pain.
However, arguing against any transition from TMD  to FMS,
Pfau et al. (2009)18 described a sensitive TMD  subgroup that
resembles FMS  patients, but they ranked in-between them
and healthy controls. In addition, FMS patients reported the
longest pain duration and the highest impairment in daily life
compared to sensitive and insensitive TMD.
Widespread  pain  in  TMD  and  FMS
Many  possible factors (e.g. environmental, genetic, cognitive,
behavior) related to widespread pain presence in TMD  and
FMS were found and discussed in the literature.
Among them, some ﬁndings showed that patients with
FMS and TMD symptoms such as chronic pain and stress could
increase sympathetic activity, which alters the cardiovascular
responses and makes the pain worse. Light et al.19 evaluated
10 ﬁbromyalgia, 10 TMD patients and 16 healthy controls and
their results support the hypothesis that both ﬁbromyalgia
and those with TMD often develop a dysregulation of beta-
adrenergic activity that contributes to altered cardiovascular
responses and catecholamines and severity of clinical pain.
Both FMS  and TMD are classiﬁed in the family of central
sensitivity syndromes and have several similar features in
common, e.g., sleep disturbances.20 Smith et al.21 suggested
that the association of primary insomnia and hyperalgesia at
a nonorofacial site suggests that primary insomnia may be
linked with central sensitivity and could play an etiologic role
in idiopathic pain disorders, therefore, sleep disturbances are
also considered an important risk indicator for the develop-
ment of TMD.
Although FMS patients have greater sleep impairment and
they are often described as no restorative sleep pathology (a
 o l . 2192  r e v b r a s r e u m a t
subjective experience of unrefreshing sleep),22 patients with
TMD  also had higher impairments on sleep and depression
scores23 and excessive daytime sleepiness was frequent in
patients with myofascial pain TMD.24
In patients with ﬁbromyalgia syndrome and other gener-
alized pain syndromes, stress also plays an important role
and there is a close association between exacerbation of pain
symptoms, increased anxiety, and exposure to stressors.25
As FMS,  patients with TMD  have reported higher levels
of affective distress, somatic awareness, psychosocial stress,
depression and pain catastrophizing.26 Pain catastrophizing,
or responses to pain that characterize it as being awful,
horrible, and unbearable, is increasingly recognized as an
extremely important contributor to the experience of pain.
Although chronic pain and psychiatric conditions often co-
occur, studies have found catastrophizing to be associated
with pain and pain-related disability independent of the inﬂu-
ence of depression.13
In addition, supporting the possible role of genetic factors
in the etiology of ﬁbromyalgia, one major locus for ﬁbromyal-
gia on the chromosome 17p11.2–q11.2 region was detected and
this chromosome region coincides with the map  coordinate
for 2 potential candidate genes for ﬁbromyalgia: the serotonin
transporter gene (SLC6A4) and the transient receptor potential
vanilloid channel 2 gene (TRPV2).27
Recently, cases with localized TMD  differed from healthy
controls in allelic frequency of single nucleotide polymor-
phisms (SNPs) that mapped to a serotonergic receptor
pathway, while cases of TMD  with widespread pain differed
in allelic frequency of SNPs that mapped to a T-cell receptor
pathway.28
Muscle  impairment
Muscles as a possible source of pain in ﬁbromyalgia have been
studied extensively. Donaldson et al.29 examined the electrical
characteristics (by surface electromyography) of diffuse mus-
cular coactivation associated with the tender points of FMS. It
is deﬁned as an increase from resting levels (tonus) in the elec-
trical activity of any muscle during a movement, which does
not involve that muscle and is not part of the agonist. The
results show an increase in electrical activity in FMS patients
as compared to controls. Coactivation was stronger proximal
to the neck and decreased in intensity as the area recorded
moved distally.
Pain and restricted movement  in the neck area is connected
to the limitation in the jaw opening30 and an association
between the function of the masticatory muscles and tem-
poromandibular joints and the mobility of cervical spine and
tenderness of the neck-shoulder muscles was found.31 Trapez-
ius muscle has an important FMS  tender point and can be
highlighted that upper trapezius muscle (innervated by cranial
nerve XI) and masticatory muscles (e.g. masseter and tempo-
ralis) are striated muscles that arise embryologically from the
branchial arches.32
The local and referred pain elicited from active trigger
points in the masticatory and neck-shoulder muscles shared
similar pain pattern as spontaneous TMD,  which supports the
concept of peripheral and central sensitization mechanisms
in myofascial TMD.33 0 1 5;5 5(2):189–194
It was suggested that sensitization of muscle nociceptors
is revealed by abnormal patterns of reﬂex motor neuron acti-
vation in patients with FMS.34 A different pattern of muscle
activation was observed in the FMS group when compared
with the TMD group, it seems that muscles impaired by
FMS  could already present a condition of premature interrup-
tion of muscle contraction, contraction may have occurred,
discharging the motor units at higher frequencies (tetanic con-
traction) in order to activate the required contraction, which is
even more  fatiguing, generating a cycle of muscle fatigue and
pain.35
Elert et al.36 also suggest that the FMS  patients had an
inability to relax the muscle throughout their bodies between
tasks and an other study reported that FMS  had signiﬁcantly
higher conduction velocity in trapezius muscle contractions
of single motor units,37 i.e. increasing the number of active
motor units.
Discussion
The literature ﬁndings demonstrate greater involvement of
the stomatognathic system in ﬁbromyalgia and myogenic dis-
orders of masticatory system are most commonly found in
those patients. Fibromyalgia syndrome appears to have a
series of characteristics that constitute predisposing and trigg-
ering factors for TMD.
On the other hand, widespread pain in TMD  should not be
confounded as ﬁbromyalgia, but instead as suggested by Pfau
et al. (2009)18 there is a subgroup of TMD patients that have
become more  sensitive to pain.
Main similarities and differences between them are,
respectively, widespread pain presence with psychological
distress, and the prevalence and severity of symptoms, which
are higher in FMS patients (e.g. sleep problems, depression,
somatization, pain).
Although these two syndromes appear to overlap, the
literature has shown that possibly the pathophysiology is
different, mainly due to a strong genetic component of
ﬁbromyalgia,27 also considering that environmental factors
inﬂuence the occurrence of the phenotype. Our review
of literature also presented many  studies suggesting that
ﬁbromyalgia can lead to TMD symptoms, but they have cross-
sectional designs that prevent temporal conclusions (cause
and consequence) from being drawn.
Psychosocial factors like sleep problems, abnormal neu-
romuscular response and central sensitization, acting con-
comitantly in FMS, could easily exceed the limit of functional
adaptation to stress in the temporomandibular system leading
to its dysfunction and pain.35
TMD cases also reported higher levels of psychological and
affective distress, greater perceived stress and catastrophiz-
ing, and increased somatic awareness compared to controls.26
Similar ﬁndings supporting psychosocial variables as premor-
bid risk factors for development of chronic pain have been
reported for other chronic pain conditions, including chronic
widespread pain, i.e., ﬁbromyalgia.38
Widespread pain, depression, and sleep disorders associ-
ated with FMS may play a signiﬁcant role in the chronicity of
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MD  in patients with FMS,39 thereby, also acting as perpetu-
ting factors for TMD.
onclusion
ibromyalgia syndrome presents a set of conditions that
onstitute predisposing and triggering factors for temporo-
andibular disorders and could explain the high prevalence
f TMD  signs and symptoms in these patients.
onﬂicts  of  interest
he authors declare no conﬂicts of interest.
 e  f  e  r  e  n  c  e  s
1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C,
Goldenberg DL, et al. The American College of Rheumatology
1990 criteria for the classiﬁcation of ﬁbromyalgia. Arthritis
Rheum. 1990;33:160–72.
2. Wolfe F, Clauw DJ, Fitzcharles M, Goldenberg DL, Katz RS,
Mease P, et al. The American College of Rheumatology
preliminary diagnostic criteria for ﬁbromyalgia and
measurement of symptom severity. Arthritis Care Res.
2010;62:600–10.
3. Ohrbach R, Fillingim RB, Mulkey F, Gonzalez Y, Gordon S,
Gremillion H, et al. Clinical ﬁndings and pain symptoms as
potential risk factors for chronic TMD: descriptive data and
empirically identiﬁed domains from the OPPERA case-control
study. J Pain. 2011;12:T27–45.
4. Hedenberg-Magnusson B, Ernberg M, Kopp S. Presence of
orofacial pain and temporomandibular disorder in
ﬁbromyalgia. A study by questionnaire. Swed Dent J.
1999;23:185–92.
5. Pimentel MJ, Gui MS, Martins de Aquino LM, Rizzatti-Barbosa
CM. Features of temporomandibular disorders in ﬁbromyalgia
syndrome. J Cranio Pract. 2013;31:40–5.
6. Salvetti G, Manfredini D, Bazzichi L, Bosco M. Clinical features
of the stomatognathic involvement in ﬁbromyalgia
syndrome: a comparison with temporomandibular disorders
patients. J Cranio Pract. 2007;25:127–33.
7. Plesh O, Wolfe F, Lane N. The relationship between
ﬁbromyalgia and temporomandibular disorders: prevalence
and symptom severity. J Rheumatol. 1996;23:1948–52.
8. Rhodus NL, Fricton J, Carlson P, Messner R. Oral symptoms
associated with ﬁbromyalgia syndrome. J Rheumatol.
2003;30:1841–5.
9. Balasubramaniam R, de Leeuw R, Zhu H, Nickerson RB,
Okeson JP, Carlson CR. Prevalence of temporomandibular
disorders in ﬁbromyalgia and failed back syndrome patients:
a blinded prospective comparison study. Oral Surg Oral Med
Oral  Pathol Oral Radiol Endod. 2007;104:204–16.
0. Leblebici B, Pektas¸ ZÖ, Ortancil Ö, Hürcan EC, Bagis S, Akman
MN. Coexistence of ﬁbromyalgia, temporomandibular
disorder, and masticatory myofascial pain syndromes.
Rheumatol Int. 2007;27:541–4.
1. Fujarra FJC [Dissertac¸ão] Disfunc¸ão temporomandibular e
síndrome ﬁbromiálgica: caracterizac¸ão de amostra segundo
critérios clínicos. São Paulo: Faculdade de Medicina da
Universidade de São Paulo; 2008.2. Dworkin SF, LeResche L, DeRouen T, Von Korff M. Assessing
clinical signs of temporomandibular disorders: reliability of
clinical examiners. J Prosthet Dent. 1990;63:574–9.
3 5;5 5(2):189–194 193
3. Williams DA, Clauw DJ. Understanding ﬁbromyalgia: lessons
from the broader pain research community. J Pain.
2009;10:777–91.
4. Adler GK, Manfredsdottir VF, Creskoff KW. Neuroendocrine
abnormalities in ﬁbromyalgia. Curr Pain Headache Rep.
2002;6:289–98.
5. Saltareli S, Pedrosa DFA, Hortense P, Sousa F. Avaliac¸ão de
aspectos quantitativos e qualitativos da dor na ﬁbromialgia.
Rev  Bras Reumatol. 2008;48:151–6.
6. Chen H, Slade G, Lim PF, Miller V, Maixner W,  Diatchenko L.
Relationship between temporomandibular disorders,
widespread palpation tenderness, and multiple pain
conditions: a case-control study. J Pain. 2012;13:1016–27.
7. Granges G, Littlejohn G. Prevalence of myofascial pain
syndrome in ﬁbromyalgia syndrome and regional pain
syndrome: a comparative study. J Musculoskelet Pain.
1993;1:19–35.
8. Pfau DB, Rolke R, Nickel R, Treede RD, Daublaender M.
Somatosensory proﬁles in subgroups of patients with
myogenic temporomandibular disorders and ﬁbromyalgia
syndrome. Pain. 2009;147:72–83.
9. Light KC, Bragdon EE, Grewen KM, Brownley KA, Girdler SS,
Maixner W.  Adrenergic dysregulation and pain with and
without acute beta-blockade in women with ﬁbromyalgia and
temporomandibular disorder. J Pain. 2009;10:542–52.
0. Yunus MB. Fibromyalgia and overlapping disorders: the
unifying concept of central sensitivity syndromes. Semin
Arthritis Rheum. 2007;36:339–56.
1. Smith MT, Wickwire EM, Grace EG, Edwards RR, Buenaver LF,
Peterson S, et al. Sleep disorders and their association with
laboratory pain sensitivity in temporomandibular joint
disorder. Sleep. 2009;32:779–90.
2. Stone KC, Taylor DJ, McCrae CS, Kalsekar A, Lichstein KL.
Nonrestorative sleep. Sleep Med Rev. 2008;12:275–88.
3. Selaimen C, Jeronymo J, Brilhante DP, Grossi ML. Sleep and
depression as risk indicators for temporomandibular
disorders in a cross-cultural perspective: a case-control study.
Int J Prosthodont. 2006;19:154–61.
4. Collesano V, Segu M, Masseroli C, Manni R.
Temporomandibular disorders and sleep disorders: which
relationship? Minerva Stomatol. 2004;53:661–8.
5. Green PG, Alvarez P, Gear RW, Mendoza D, Levine JD. Further
validation of a model of ﬁbromyalgia syndrome in the rat. J
Pain. 2011;12:811–8.
6. Fillingim RB, Ohrbach R, Greenspan JD, Knott C, Dubner R,
Bair  E, et al. Potential psychosocial risk factors for chronic
TMD: descriptive data and empirically identiﬁed domains
from the OPPERA case-control study. J Pain. 2011;12:T46–60.
7. Arnold LM, Fan J, Russell IJ, Yunus MB, Khan MA, Kushner I,
et al. The ﬁbromyalgia family study: a genome-wide linkage
scan study. Arthritis Rheum. 2013;65:1122–8.
8. Slade GD, Smith SB, Zaykin DV, Tchivileva IE, Gibson DG,
Yuryev A, et al. Facial pain with localized and widespread
manifestations: separate pathways of vulnerability. Pain.
2013;154:2335–43.
9. Donaldson C, MacInnis A, Snelling L, Sella G, Mueller H.
Characteristics of diffuse muscular coactivation (DMC) in
persons with ﬁbromyalgia – part 2. Neuro Rehabil.
2002;17:41–8.
0. Eriksson P, Häggman-Henrikson B, Zafar H. Jaw–neck
dysfunction in whiplash-associated disorders. Arch Oral Biol.
2007;52:404–8.
1. Sipilä K, Suominen AL, Alanen P, Heliövaara M,  Tiittanen P,
Könönen M. Association of clinical ﬁndings of
temporomandibular disorders (TMD) with self-reported
musculoskeletal pains. Euro J Pain. 2011;15:1061–7.
2. Goetz CG. Textbook of clinical neurology. Elsevier Health
Sciences; 2007.






3194  r e v b r a s r e u m a t
3. Fernández-de-las-Pen˜as C, Galán-del-Río F, Alonso-Blanco C,
Jiménez-García R, Arendt-Nielsen L, Svensson P. Referred
pain from muscle trigger points in the masticatory and
neck-shoulder musculature in women with
temporomandibular disorders. J Pain. 2010;11:1295–304.
4. Vierck CJ Jr. Mechanisms underlying development of spatially
distributed chronic pain (ﬁbromyalgia). Pain. 2006;124:242–63.
5. Gui MS, Pedroni CR, Aquino LMM, Pimentel MJ, Alves MC,
Rossini S, et al. Facial pain associated with ﬁbromyalgia can
be  marked by abnormal neuromuscular control: a
cross-sectional study. Phys Ther. 2013;93:1092–101.
6. Elert J, Rantapää-Dahlqvist S, Henriksson-Larsen K, Lorentzon
R, Gerdle B. Muscle performance, electromyography and ﬁbre
3 0 1 5;5 5(2):189–194
type composition in ﬁbromyalgia and work-related myalgia.
Scand J Rheumatol. 1992;21:28–34.
7. Gerdle B, Östlund N, Grönlund C, Roeleveld K, Karlsson JS.
Firing rate and conduction velocity of single motor units in
the trapezius muscle in ﬁbromyalgia patients and healthy
controls. J Electromyogr Kinesiol. 2008;18:707–16.
8. McBeth J, Macfarlane GJ, Benjamin S, Silman AJ. Features of
somatization predict the onset of chronic widespread pain:
results of a large population-based study. Arthritis Rheum.
2001;44:940–6.
9. Fricton JR. The relationship of temporomandibular disorders
and  ﬁbromyalgia: implications for diagnosis and treatment.
Curr Pain Headache Rep. 2004;8:355–63.
